WST · 10-Q · 2026Q3 · Full report

Liquidity and Debt Position

WEST PHARMACEUTICAL SERVICES INC · 2026-10-29 · Importance 51 · Surprise 38

At September 30, 2026, West held $464.1 million in cash and cash equivalents and had total debt of $202.9 million, essentially unchanged from $202.8 million at December 31, 2025. The company had no borrowings under its multi-currency revolving credit facility and had $497.7 million of available borrowing capacity, including $2.3 million of outstanding letters of credit. West reported compliance with all debt covenants and said cash, operating cash generation, and revolving-credit availability would cover foreseeable liquidity needs. On October 26, 2026, the company completed a refinancing of its senior unsecured credit facilities.

Key facts

• WEST PHARMACEUTICAL SERVICES INC had no outstanding borrowings under its multi-currency revolving credit facility at September 30, 2026; available borrowing capacity, including $2.3 million of outstanding letters of credit, was $497.7 million. source
• WEST PHARMACEUTICAL SERVICES INC had $202.9 million of debt at September 30, 2026, compared with $202.8 million at December 31, 2025. source
• WEST PHARMACEUTICAL SERVICES INC completed a refinancing of its senior unsecured credit facilities on October 26, 2026. source
• WEST PHARMACEUTICAL SERVICES INC stated that cash on hand, cash generated from operations, and available revolving-credit-facility capacity would be adequate for foreseeable liquidity needs based on current expectations. source
• WEST PHARMACEUTICAL SERVICES INC was in compliance with all debt covenants at September 30, 2026. source